JP2014506233A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506233A5 JP2014506233A5 JP2013538290A JP2013538290A JP2014506233A5 JP 2014506233 A5 JP2014506233 A5 JP 2014506233A5 JP 2013538290 A JP2013538290 A JP 2013538290A JP 2013538290 A JP2013538290 A JP 2013538290A JP 2014506233 A5 JP2014506233 A5 JP 2014506233A5
- Authority
- JP
- Japan
- Prior art keywords
- emodin
- digoxin
- medicament
- agent
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 claims 10
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 claims 10
- 239000010282 Emodin Substances 0.000 claims 10
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 claims 10
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 claims 10
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 claims 10
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 claims 10
- 229960005156 digoxin Drugs 0.000 claims 10
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 claims 10
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 claims 10
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 claims 10
- 239000003795 chemical substances by application Substances 0.000 claims 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 241000219061 Rheum Species 0.000 claims 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 208000032839 leukemia Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 241001648835 Polygonum cuspidatum Species 0.000 claims 1
- 235000018167 Reynoutria japonica Nutrition 0.000 claims 1
- 241000219100 Rhamnaceae Species 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41343010P | 2010-11-13 | 2010-11-13 | |
| US61/413,430 | 2010-11-13 | ||
| US13/018,435 | 2011-02-01 | ||
| US13/018,435 US8541382B2 (en) | 2010-11-13 | 2011-02-01 | Cardiac glycoside analogs in combination with emodin for cancer therapy |
| PCT/IB2011/003078 WO2012063134A2 (en) | 2010-11-13 | 2011-11-13 | Cardiac glycoside analogs in combination with emodin for cancer therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506233A JP2014506233A (ja) | 2014-03-13 |
| JP2014506233A5 true JP2014506233A5 (OSRAM) | 2015-01-08 |
| JP5961622B2 JP5961622B2 (ja) | 2016-08-02 |
Family
ID=46048345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013538290A Expired - Fee Related JP5961622B2 (ja) | 2010-11-13 | 2011-11-13 | 癌治療のための、エモジンと併用する強心配糖体アナログ |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US8541382B2 (OSRAM) |
| EP (1) | EP2637671A4 (OSRAM) |
| JP (1) | JP5961622B2 (OSRAM) |
| WO (1) | WO2012063134A2 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9095606B1 (en) | 2010-11-13 | 2015-08-04 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
| US8541382B2 (en) | 2010-11-13 | 2013-09-24 | Sirbal Ltd. | Cardiac glycoside analogs in combination with emodin for cancer therapy |
| US9066974B1 (en) | 2010-11-13 | 2015-06-30 | Sirbal Ltd. | Molecular and herbal combinations for treating psoriasis |
| US20170049835A1 (en) | 2015-07-29 | 2017-02-23 | Sirbal Ltd. | Herbal Combinations For Treating Scalp Conditions |
| US9561245B2 (en) | 2012-09-06 | 2017-02-07 | The Board Of Regents Of The University Of Texas System | Combination treatments for melanoma |
| US20140080772A1 (en) * | 2012-09-06 | 2014-03-20 | The Board Of Regents Of The University Of Texas System | Treatments for melanoma |
| US9572828B2 (en) * | 2013-07-18 | 2017-02-21 | The Board Of Regents Of The University Of Texas System | Treatment for melanoma |
| EP3586858A1 (en) | 2015-10-01 | 2020-01-01 | Photodynamic Inc. | Novel polygonum cuspidatum extracts and their use as photodynamic inactivating agents |
| US9795570B2 (en) * | 2016-03-17 | 2017-10-24 | University Of South Carolina | Modulation of macrophage phenotype by emodin |
| US20240076666A1 (en) * | 2021-02-12 | 2024-03-07 | The Regents Of The University Of California | Immunomodulators Targeting MORC3 for Interferon Induction |
| JP2023086330A (ja) * | 2021-12-10 | 2023-06-22 | 株式会社アミノエース | がん細胞の増殖抑制用組成物 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2068027A (en) * | 1935-05-09 | 1937-01-19 | Rare Chemicals Inc | Process of making glucosides from digitalis purpurea |
| US5872103A (en) | 1986-11-26 | 1999-02-16 | Belletti; Dino A. | Prevention of mammary tumors by treatment with cardiac glycosides |
| JPH06321795A (ja) | 1993-05-07 | 1994-11-22 | Kuga Takaaki | アトピー性皮膚炎等の皮膚疾患治療薬 |
| US6326356B1 (en) | 1996-10-18 | 2001-12-04 | Board Of Regents, The University Of Texas System | Suppression of neu overexpression using a mini-E1A gene |
| WO1997027848A1 (en) * | 1996-01-31 | 1997-08-07 | Board Of Regents, The University Of Texas System | SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS |
| KR100221762B1 (ko) | 1996-10-29 | 1999-09-15 | 이승기 | 에모딘의 항암제로서의 용도 |
| SG60053A1 (en) | 1997-04-10 | 1999-02-22 | Chang Teh Shan | Herb composition and an herbal plaster made from the same |
| AU760766B2 (en) | 1998-08-18 | 2003-05-22 | Regents Of The University Of California, The | Preventing airway mucus production by administration of EGF-R antagonists |
| US6740665B1 (en) | 1999-02-10 | 2004-05-25 | Ramachandran Murali | Tyrosine kinase inhibitors and methods of using the same |
| ES2358639T3 (es) | 2000-03-09 | 2011-05-12 | Yale University | Composición que consiste en phy906 y agentes quimioterapéuticos. |
| US7534455B2 (en) | 2000-03-09 | 2009-05-19 | Yale University | Herbal composition PHY906 and its use in chemotherapy |
| IT1318547B1 (it) | 2000-05-31 | 2003-08-27 | Giorgio Palu | Impiego dell'aloe-emodin nel trattamento di patologie neoplastiche diorigine neuroectodermica. |
| CN1369276A (zh) * | 2001-02-12 | 2002-09-18 | 徐秀荣 | 有效减轻体重的组合物和方法 |
| US20030125265A1 (en) * | 2001-05-09 | 2003-07-03 | Mien-Chie Hung | Anti-estrogen receptor agents for chemotherapy |
| ITMI20010957A1 (it) | 2001-05-10 | 2002-11-10 | Giorgio Palu | Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche |
| US20080220441A1 (en) | 2001-05-16 | 2008-09-11 | Birnbaum Eva R | Advanced drug development and manufacturing |
| AU2002365421A1 (en) | 2001-07-10 | 2003-09-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting the activation state of the multiple proteins in single cells |
| US7381535B2 (en) | 2002-07-10 | 2008-06-03 | The Board Of Trustees Of The Leland Stanford Junior | Methods and compositions for detecting receptor-ligand interactions in single cells |
| US7695926B2 (en) | 2001-07-10 | 2010-04-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting receptor-ligand interactions in single cells |
| US7393656B2 (en) | 2001-07-10 | 2008-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for risk stratification |
| US7790905B2 (en) | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| CN1370587A (zh) | 2002-03-05 | 2002-09-25 | 王舒妍 | 芦荟凝胶的制备方法 |
| JP2006510674A (ja) | 2002-12-06 | 2006-03-30 | ボード オブ リージェンツ ザ ユニバーシティー オブ テキサス システム | 脂質：エモジン製剤に関する組成物および方法 |
| US20050026849A1 (en) | 2003-03-28 | 2005-02-03 | Singh Chandra U. | Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases |
| US20060229267A1 (en) | 2004-06-01 | 2006-10-12 | Reza Sheikhnejad | Methods and compositions for the inhibition of gene expression |
| US20060205679A1 (en) | 2004-10-22 | 2006-09-14 | Azaya Therapeutics, Inc. | Topical and oral formulations of cardiac glycosides for treating skin diseases |
| CN1796400B (zh) | 2004-12-29 | 2010-06-23 | 杭州浙大力夫生物科技有限公司 | 从竹笋中提取的植物甾醇类提取物及其制备方法和用途 |
| EP1891218A2 (en) | 2005-06-08 | 2008-02-27 | Compugen Ltd. | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| US7402325B2 (en) | 2005-07-28 | 2008-07-22 | Phoenix Biotechnology, Inc. | Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander |
| US20070191262A1 (en) | 2005-11-15 | 2007-08-16 | University Of Iowa Research Foundation | Cancer Therapy and Prevention Based on Modulation of Complement activity |
| AU2006343317A1 (en) | 2006-05-09 | 2007-11-15 | University Of Louisville Research Foundation | Treating cancer with cardiac glycosides |
| US20090018088A1 (en) | 2006-10-27 | 2009-01-15 | University Of Louisville Research Foundation | Treating cancer with cardiac glycosides |
| AU2006350507A1 (en) | 2006-11-09 | 2008-05-15 | Unibioscreen S.A. | Targeting of alpha-1 or alpha-3 subunit of Na+, K+-ATPase in the treatment of proliferative diseases |
| CA2678427C (en) | 2007-02-16 | 2016-06-07 | Ktb Tumorforschungsgesellschaft Mbh | Dual acting prodrugs |
| WO2008156654A2 (en) | 2007-06-15 | 2008-12-24 | Massachusetts Institute Of Technology | Cytoskeleton modulators for treating metabolic disorders |
| RU2571687C2 (ru) | 2007-11-13 | 2015-12-20 | Феникс Байотекнолоджи Инк. | Набор для определения вероятности терапевтического ответа на противораковую химиотерапию сердечным гликозидом |
| WO2009151511A1 (en) | 2008-04-29 | 2009-12-17 | Therasis, Inc. | Systems and methods for identifying combinations of compounds of therapeutic interest |
| US8669048B2 (en) | 2008-06-24 | 2014-03-11 | Parkinson's Institute | Pluripotent cell lines and methods of use thereof |
| CN101362702B (zh) | 2008-09-12 | 2012-06-20 | 南昌大学 | 大黄素衍生物及其在制备抗癌药物中的应用 |
| AU2009303460B9 (en) | 2008-10-14 | 2014-12-18 | Nerium Biotechnology, Inc. | Process for extracting cardiac glycodides and compositions |
| US8597695B1 (en) * | 2010-11-13 | 2013-12-03 | Sirbal Ltd. | Herbal combinations for treatment of a skin condition |
| US8541382B2 (en) | 2010-11-13 | 2013-09-24 | Sirbal Ltd. | Cardiac glycoside analogs in combination with emodin for cancer therapy |
-
2011
- 2011-02-01 US US13/018,435 patent/US8541382B2/en not_active Expired - Fee Related
- 2011-11-13 WO PCT/IB2011/003078 patent/WO2012063134A2/en not_active Ceased
- 2011-11-13 JP JP2013538290A patent/JP5961622B2/ja not_active Expired - Fee Related
- 2011-11-13 EP EP11839034.3A patent/EP2637671A4/en not_active Withdrawn
-
2013
- 2013-09-23 US US14/034,423 patent/US20140206631A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014506233A5 (OSRAM) | ||
| Brys et al. | Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy | |
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| HRP20211177T1 (hr) | Korteksolon 17alfa-valerat za uporabu u liječenju tumora | |
| PH12017500023A1 (en) | Targeted conjugates and particles and formulations thereof | |
| EP2937697A4 (en) | GPC3-AIMED THERAPEUTIC FOR THE ADMINISTRATION TO A THERAPY-BASED TREATMENT OF GPC3-TARGETED THERAPEUTIC TREATED PATIENTS | |
| JP2015500225A5 (OSRAM) | ||
| MX360098B (es) | Conjugados dirigidos encapsulados en partículas y sus formulaciones. | |
| CA3201974C (en) | Nanoparticle drug conjugates | |
| JP2011079858A5 (OSRAM) | ||
| EA033456B1 (ru) | Конъюгаты антитело-лекарственное средство, содержащие пептидомиметические линкеры | |
| CL2013003497A1 (es) | Producto farmacéutico de combinación en forma de polvo seco para administración por medio de un inhalador que comprende una sal de umeclidinio de un grupo definido y 100 mcg/dosis de furoato de fluticasona, sin otros activos adicionales; uso para el tratamiento de enfermedades inflamatorias o del aparato respiratorio. | |
| JP2011522515A5 (OSRAM) | ||
| JP2015528491A5 (OSRAM) | ||
| GT200900128A (es) | Antagonistas del receptor de progesterona | |
| TR201109804A2 (tr) | Tek dozlu inhalasyon cihazı. | |
| AR093382A1 (es) | Dispositivo de administracion de farmacos para el tratamiento de pacientes con enfermedades respiratorias | |
| MY165888A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
| WO2015114166A3 (en) | Targeted drug conjugates | |
| RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения | |
| CN111655295A (zh) | 抗her2抗体药物偶联物在治疗尿路上皮癌中的用途 | |
| WO2016040462A3 (en) | Formulations and methods for treatment of metabolic syndrome | |
| JP2015507020A5 (OSRAM) | ||
| JO3737B1 (ar) | تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان | |
| JP2015500286A5 (OSRAM) |